73 related articles for article (PubMed ID: 21830438)
21. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor receptor-3 is a favorable prognostic factor in advanced gastric carcinoma.
Sung JY; Lee S; Kim YW; Park YK
Oncol Rep; 2008 Apr; 19(4):939-44. PubMed ID: 18357379
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
[TBL] [Abstract][Full Text] [Related]
24. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
26. [Superficial cancer of the stomach in the area of Calvados from 1978 to 1990. Epidemiology and prognostic factors].
Arsène D; Gignoux M; Pottier D; Rougereau A; Even C; Dao T; Verwaerde JC; Rousselot P
Gastroenterol Clin Biol; 1998 Jan; 22(1):6-12. PubMed ID: 9762159
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
[TBL] [Abstract][Full Text] [Related]
28. Relationship between the long-term effects of intraperitoneal chemotherapy and the expression of p53 and p21 in patients with gastric carcinoma at stage IIIa and stage IIIb.
Ikeguchi M; Saito H; Katano K; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Int Surg; 1997; 82(2):170-4. PubMed ID: 9331847
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of cancer-related symptoms in recurrent gastric cancer patients.
Kosuga T; Ichikawa D; Komatsu S; Okamoto K; Fujiwara H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Shiozaki A; Kokuba Y; Sonoyama T; Otsuji E
Hepatogastroenterology; 2011; 58(105):213-7. PubMed ID: 21510317
[TBL] [Abstract][Full Text] [Related]
30. Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures.
Pugliese R; Maggioni D; Sansonna F; Ferrari GC; Forgione A; Costanzi A; Magistro C; Pauna J; Di Lernia S; Citterio D; Brambilla C
Eur J Surg Oncol; 2009 Mar; 35(3):281-8. PubMed ID: 18342480
[TBL] [Abstract][Full Text] [Related]
31. Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy?
Moriwaki Y; Kunisaki C; Kobayashi S; Harada H; Imai S; Kasaoka C
Hepatogastroenterology; 2003; 50(49):284-8. PubMed ID: 12630042
[TBL] [Abstract][Full Text] [Related]
32. Appropriate gastric resection with lymph node dissection for early gastric cancer.
Borie F; Plaisant N; Millat B; Hay JM; Fagniez PL;
Ann Surg Oncol; 2004 May; 11(5):512-7. PubMed ID: 15078634
[TBL] [Abstract][Full Text] [Related]
33. Gastric cancer in Poland - clinical characteristics and results of surgery.
Zielinski J; Jaworski R; Kabata P; Kruszewski WJ; Jaskiewicz J
Dig Surg; 2010; 27(5):409-16. PubMed ID: 20948215
[TBL] [Abstract][Full Text] [Related]
34. Gastric carcinoma invading muscularis propria and macroscopic appearance.
Maehara Y; Anai H; Moriguchi S; Watanabe A; Tsujitani S; Sugimachi K
Eur J Surg Oncol; 1992 Apr; 18(2):131-4. PubMed ID: 1582506
[TBL] [Abstract][Full Text] [Related]
35. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Kim S
Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.
Nekarda H; Schmitt M; Ulm K; Wenninger A; Vogelsang H; Becker K; Roder JD; Fink U; Siewert JR
Cancer Res; 1994 Jun; 54(11):2900-7. PubMed ID: 8187075
[TBL] [Abstract][Full Text] [Related]
37. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
Song KY; Jung CK; Park WS; Park CH
Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.
Potrc S; Gadiijev E; Hajdinjak T; Kavalar R
Hepatogastroenterology; 2007; 54(73):308-14. PubMed ID: 17419281
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics of lymph node metastasis and prognostic analysis in 157 early gastric cancer patients].
Wu ZM; Wu AW; Li ZY; Wu Q; Zhang LH; Wu XJ; Zong XL; Ji JF; Bu ZD
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):350-3. PubMed ID: 19598016
[TBL] [Abstract][Full Text] [Related]
40. Survival in early gastric cancer: multivariate analysis on 72 consecutive cases.
Pacelli F; Doglietto GB; Alfieri S; Carriero C; Malerba M; Crucitti PF; Caprino P; Crucitti F
Hepatogastroenterology; 1999; 46(26):1223-8. PubMed ID: 10370696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]